OICR leadership

Peter Goodhand

Interim President, Executive Director of the Global Alliance for Genomics and Health 

More details  →

Lincoln Stein

Interim Scientific Director at OICR, Program Director, Informatics

More details

Christine Williams

Deputy Director

More details

Jeanette Dias D'Souza

Chief Financial Officer.

More details

Michele Noble

Corporate Secretary.

More details

Jeff Courtney

President, FACIT

More details

Board of Directors

Tom Closson

Chair
Principal, Tom Closson Consulting

More details  →

Sharon M. Chandler

Member-at-Large, Canadian Cancer Society Ontario Board

More details

Roger Deeley, PhD

Vice President Health Sciences Research, Kingston General Hospital

More details  →

Peter Fullerton

Retired Partner, Grant Thornton, LLP

More details  →

Dennis Giokas

President of Theoria Health Innovations Inc. 

More details  →

Christopher Paige, PhD, FCAHS

Senior Scientist, University Health Network and Head, UHN International Research Services

More details  →

Michael Sherar, PhD

President and CEO, Cancer Care Ontario

More details  →

Douglas Squires, PhD

Former Chairman of the Board, Biovail Corporation

More details  →

Samuel Weiss, PhD

Director, Hotchkiss Brain Institute, University of Calgary

More details  →

Daniel Woolf, PhD

Principal and Vice-Chancellor, Queen’s University

More details  →

Scientific Advisory Board

Karen Gelmon, MD
  • Senior Scientist, Medical Oncologist, BC Cancer Agency, Vancouver Centre;
  • Head, Investigational Drug Program, Experimental Therapeutics, Department of Medical Oncology, BC Cancer Agency;
  • Professor, Medicine, University of British Columbia.
Eric Lander, PhD
  • Member of, Whitehead Institute for Biomedical Research, MIT;
  • Professor of Systems Biology, Harvard Medical School;
  • Professor of Biology, Massachusetts Institute of Technology (MIT);
  • Founding Director, Broad Institute.
Patricia Ganz, MD
  • Distinguished University Professor, David Geffen School of Medicine at UCLA;
  • Director, Jonsson Comprehensive Cancer Center Los Angeles, California.
David Mankoff, MD
  • Professor Radiology, Medicine and Bioengineering, University of Washington.
Michael Morin, PhD
  • President and CSO, Immunome, Inc.
Dennis Sgroi, MD
  • Associate Pathologist, Director of Breast Pathology and Associate Professor of Pathology, Massachussetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
George W. Sledge, MD
  • Balive-Lantero Professor of Oncology, Co-Director, Breast Cancer Program, Indiana University Cancer Care Center;
  • Professor of Medicine and Pathology, Indiana University School of Medicine.